Survival outcomes of rectal and head and neck cancer patients receiving radio-(chemo)therapy with a ketogenic diet. Results from a controlled clinical study (KETOCOMP)
Klement, R. J.; Sweeney, R. A.
Show abstract
BackgroundHigh-fat, low carbohydrate ketogenic diets (KDs) have been proposed to target the cancer hallmark of high glycolytic metabolism and synergize with radio- and chemotherapy. We here report survival outcomes of rectal and head and neck cancer (HNC) patients who underwent a KD during radio-(chemo)therapy. Materials and MethodsPatients had participated in the controlled KETOCOMP study. The intervention group had consumed a KD during radiotherapy, while the control group had maintained their standard diet. All patients were prospectively followed until the occurrence of disease progression or death to evaluate overall (OS), progression-free (PFS) and locoregional recurrence-free survival (RFS) with the Kaplan-Meier method and by computing restricted mean survival times. In order to simulate a randomized controlled trial and meta-analysis, patients in the KD groups were matched to control patients with propensity score matching and data was pooled. ResultsMedian follow-up was 77.4 (range 12.1-107.9) months (HNC) and 72.6 (16.5-127.1) months (rectal cancer), respectively. HNC patients exhibited non-significantly longer OS and PFS and a trend for longer RFS times (p=0.079). These trends became more pronounced in the propensity score-matched sample (log-rank test p-values <0.10 for all three outcomes). In rectal cancer patients, there was no evidence for a benefit of the KD group. Analysis of the matched and pooled sample revealed a significantly longer restricted mean PFS time in the KD group (p=0.027) and a trend for longer RFS times (p=0.062). OS was also longer in the pooled KD group, but not significantly (p=0.29). ConclusionsThese data indicate the potential for synergistic effects of a KD combined with radio-(chemo)therapy. While sample sizes could have prohibited the observed survival differences from becoming statistically significant, our data are useful to inform future studies or meta-analyses.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Quality of life and patient-reported outcomes following proton therapy for oropharyngeal carcinoma: a systematic review 93%
- NDRG1 expression is an independent prognostic factor in inflammatory breast cancer 93%
- Hormone Receptor-status Prediction in Breast Cancer Using Gene Expression Profiles and Their Macroscopic Landscape 92%
Similar papers in this journal
- Study Protocol of A Phase II Study to Evaluate Safety and Efficacy of Neo-adjuvant Pembrolizumab and Radiotherapy in Localized Rectal Cancer 96%
- Feasibility of Administering Human Pancreatic Cancer Chemotherapy in a Spontaneous Pancreatic Cancer Mouse Model 95%
- ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer 93%
Similar papers in this journal
- Meta-Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell Carcinoma 93%
- mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms 92%
- Establishment and validation of pre-therapy cervical vertebrae muscle quantification as a prognostic marker of sarcopenia in head and neck patients receiving definitive cancer surgery 92%
Similar papers in this journal
- Interventions with dietary supplements, including pre-, pro- and synbiotics, to reduce acute and late gastrointestinal side effects in patients undergoing pelvic radiotherapy: A systematic review and meta-analysis 95%
- Personalized volume-deescalated elective nodal irradiation in oropharyngeal squamous cell carcinoma (DeEscO): a study protocol 94%
- Re-irradiation to the Prostate using stereotactic body radiotherapy (SBRT) after initial definitive Radiotherapy – A systematic review and Meta-analysis of recent trials 93%
Similar papers in this journal
- Dysphagia and shortness-of-breath as markers for treatment failure and survival in oropharyngeal cancer after radiation 94%
- Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interface 92%
- Artificial Intelligence Uncertainty Quantification in Radiotherapy Applications - A Scoping Review 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.